Company news

October 2025

Thirona Receives FDA Clearance for LungQ® 4 Software, Expanding AI-Powered Capabilities in Lung Image Analysis for the U.S. Market

October 2025

Thirona and VIDA Diagnostics Partner to Accelerate Respiratory Clinical Trials with Advanced AI Imaging

August 2025

Renewed ISO 13485 and MDR Approvals, and our 1st MDSAP Certification

May 2025

Welcoming internationally renowned pulmonologists to Thirona’s Medical Advisory Board

May 2025

Thirona and COPD Foundation Partner to Advance AI-Driven Phenotyping of COPD Patients

August 2024

Thirona Spinout Thirona Retina BV Acquired by Revenio Group

August 2024

Welcoming top clinical experts to Thirona’s Medical Advisory Board

May 2024

Blackford and Thirona Partner to Enhance Lung Image Analysis

May 2024

Autonomous AI Revolutionizes Cancer Detection

April 2024

Voiant and Thirona announce commercial partnership for full scope services in imaging-based clinical trials for pulmonary diseases.

February 2024

Thirona partners with Free Flow Medical for AI-powered clinical solutions to treat COPD patients

January 2024

LungQ 3.0.0 receives FDA 510(k) clearance